Neonatal Morbidities of Fetal Growth Restriction: Pathophysiology and Impact

Atul Malhotra1,2,3, Beth J Allison2,4, Margie Castillo-Melendez2,4

  • 1Monash Newborn, Monash Children's Hospital, Melbourne, VIC, Australia.

Frontiers in Endocrinology
|February 23, 2019
PubMed

Insights

Fetal growth restriction (FGR) causes babies to be born small, leading to health issues. Understanding FGR

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Developmental Biology

Background:

  • Intrauterine growth restriction (FGR) is a pregnancy complication characterized by pathological fetal growth reduction.
  • Placental insufficiency is the primary cause, leading to chronic undersupply of oxygen and nutrients to the fetus.
  • Neonatal morbidities depend on FGR onset, severity, and gestational age at birth.

Purpose of the Study:

  • To explore pathophysiological mechanisms of major neonatal morbidities in FGR.
  • To examine the impact of FGR on infant health.
  • To present clinical, diagnostic, and management strategies for neonatal morbidities.

Main Methods:

  • Review of pathophysiological mechanisms in FGR.
  • Analysis of fetal cardiovascular adaptation and organ development.
  • Compilation of clinical presentation, diagnostic tools, and management strategies.

Main Results:

  • Fetal cardiovascular adaptation and altered organ development are key contributors to postnatal consequences.
  • Neonatal morbidities vary based on FGR timing, severity, and gestational age.
  • Current targeted therapies and their status are discussed.

Conclusions:

  • Understanding FGR's pathophysiological mechanisms is crucial for neonatal health.
  • Early detection, monitoring, and management of adverse outcomes are essential.
  • Improved knowledge facilitates better care for newborns affected by FGR.

Related Concept Videos

Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
36.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
915
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.0K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K